In recent years, Decentralized Clinical Trials (DCTs) have emerged as a promising solution to enhance patient access to cutting-edge treatments. By leveraging digital technologies and remote monitoring, DCTs enable patients to participate in clinical research from the comfort of their homes. This approach not only reduces the burden of travel and site visits but also broadens participation to individuals in remote or underserved areas. As the healthcare landscape continues to evolve, DCTs represent a paradigm shift towards more patient-centric and inclusive clinical research methodologies.